On December 15th, the 4th China Biomedical Industry Chain Innovation and Transformation International Summit and the 4th China Biomedical Industry Chain Innovation Power List Awards Ceremony were jointly hosted by Hangzhou High-tech Zone Government, Yangtze River Delta Data-driven Innovative Biomedical Industry Chain Alliance, and China Biomedical Industry Chain Innovation Transformation Union in Hangzhou. During the conference, Evergreen Therapeutics was recognized as the "Annual Influential Digital Life Health Enterprise of 2023" on the power list for its exceptional contributions to promoting AI clinical practices domestically in recent years.

Conference site

The conference convened both domestic and international academic scientists, research institution leaders, and distinguished corporate executives, including Chen Kai Xian, a member of the Chinese Academy of Sciences; Pan Guangcheng, Senior President of the China Pharmaceutical Industry Association and Deputy Director-General of CBIITA Joint Body; Fu Daxu, President of Shanghai Institute for Biological Sciences; Wei Qiming, a fellow at the American College of Cardiology and American College of Chest Physicians; Zhou Demin, Chairman of the National Key Laboratory Alliance for Pharmacy.